KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Unitedhealth (UNH) EPS (Weighted Average and Diluted) (2016 - 2025)

Unitedhealth (UNH) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $0.02 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 99.67% to $0.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 through Dec 2025, down 14.84% year-over-year, with the annual reading at $13.23 for FY2025, 14.7% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.02 at Unitedhealth, down from $2.59 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $6.85 in Q1 2025, with the low at -$1.53 in Q1 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is $4.59, with a median of $5.18 recorded in 2021.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 125.71% in 2024, then surged 547.71% in 2025.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $4.26 in 2021, then increased by 18.08% to $5.03 in 2022, then rose by 16.3% to $5.85 in 2023, then rose by 2.22% to $5.98 in 2024, then tumbled by 99.67% to $0.02 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.02, $2.59, and $3.74 for Q4 2025, Q3 2025, and Q2 2025 respectively.